The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases
International Journal of Molecular Sciences · 28.02.2025 · 26 (5) · 2185
DOI: 10.3390/ijms26052185 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.02.2025. Verfasst von Cristina Quecchia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Allergy Service, Children's Hospital, ASST Spedali Civili di Brescia, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Inositol, Respiratory Tract Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Respiratory diseases are major health concerns worldwide. Chronic respiratory diseases (CRDs) are the third leading cause of death worldwide and some of the most common are chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases, and pulmonary hypertension. Despite having different etiology and characteristics, these diseases share several features, such as a persistent inflammatory state, chronic oxidative stress, impaired mucociliary clearance, and increased alveolar surface tension. CRDs are not curable; however, various forms of treatment, that help restore airway patency and reduce shortness of breath, can improve daily life for people living with these conditions. In this regard myo-inositol may represent a valid therapeutic adjuvant approach due to its properties. Being a redox balancer, an inflammation modulator, and, most importantly, a component of pulmonary surfactant, it may improve lung function and counteract symptoms associated with respiratory diseases, as recently evidenced in patients with COPD, COVID-19, asthma, and bronchiectasis. The aim of this review is to evaluate the potential therapeutic role of myo-inositol supplementation in the management of patients with respiratory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Allergy Service, Children's Hospital, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
- Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35128 Padova, Italy.
ORCID-Profile: Cristina Quecchia, Andrea Vianello
Zitieren
APA
Quecchia, C., & Vianello, A. (2025). The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases. International Journal of Molecular Sciences, 26(5), 2185. https://doi.org/10.3390/ijms26052185
Vancouver
Quecchia C, Vianello A. The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases. International Journal of Molecular Sciences. 2025;26(5):2185. doi:10.3390/ijms26052185
BibTeX
@article{Quecchia2025,
author = {Quecchia, Cristina and Vianello, Andrea},
title = {The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {5},
pages = {2185},
doi = {10.3390/ijms26052185}
}
EUVIMED